Cancer Research  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 45, 2516-2521, June 1, 1985]
© 1985 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Allen, T. E.
Right arrow Articles by Lane, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Allen, T. E.
Right arrow Articles by Lane, A.

Amplification of the Antitumor Activity of Phleomycins and Bleomycins in Rats and Mice by Caffeine

Thomas E. Allen, Natale A. Aliano, Richard J. Cowan, Geoffrey W. Grigg1, Noel K. Hart, John A. Lamberton and Alan Lane

CSIRO Division of Molecular Biology, P. O. Box 184, North Ryde, New South Wales, 2113, [T. E. A., N. A. A., G. W. G.]; CSIRO Division of Mathematics and Statistics, P. O. Box 218, New South Wales, Lindfield, 2070 [R. J. C.]; CSIRO Division of Applied Organic Chemistry, Box 4331, G. P. O., Melbourne, Victoria 3001 [N. K. H., J. A. L.]; and CSIRO Division of Food Research, P. O. Box 52, North Ryde, New South Wales, 2113 [A. L.], Australia

While having no antitumor effect per se, caffeine substantially enhanced the antitumor effects of the phleomycins PLM-CHP and PLM-PEP, and the bleomycins BLM-CHP and Blenoxane in rats carrying Walker 256 carcinosarcoma and/or mice carrying Ehrlich ascites tumor, even at doses of phleomycin and bleomycin below the minimum effective level. Positive but less conclusive results were also obtained with PLM-A4A4G and PLM-G.

1 To whom requests for reprints should be addressed.

Received 3/26/84. Revised 12/26/84. Accepted 2/ 1/85.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1985 by the American Association for Cancer Research.